New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Wednesday, November 18, 2026

Back to the front page

From X

S&P Global

S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…

Monte Investments Market Brief Vol. CXXXVI

Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…

Envisioning Entravision

Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…

SLS · short

Sellas Life Sciences Group I

SELLAS Life Sciences Group faces a short case arguing that even a strong clinical outcome does not support its current valuation.

Short CNM

Core & Main faces a short thesis centered on the risks in its roll-up strategy.

Short LUMN

Lumen Technologies faces a fading boost from its PCF-related sugar high.

Nomad Foods - The Yield Machine

Nomad Foods combines leading European frozen-food brands with a high dividend yield, buybacks and decade-low valuation, while private-label…

Doubling Down on Iran and OXY

Occidental Petroleum is positioned for oil above $80, with a prolonged Iran conflict and Gulf supply shut-ins pushing prices into triple…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

Seeking Alpha 93 of 300

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

383 firms

Sectors

Ordered by how often our editor reaches for them.